Articles and Blogs

Federal Anti-Kickback Statute

Selling Prescription Drugs Directly to Patients? OIG Flags Anti-Kickback Pitfalls with TrumpRx and Other DTC Programs

[02/13/26]

Posted on February 13, 2026 in Health Law News

Published by: Hall Render

On January 27, 2026, the U.S. Department of Health and Human Services (“HHS”) Office of the Inspector General (“OIG”) issued a Special Advisory Bulletin (the “Bulletin”) detailing how the federal Anti-Kickback Statute (“AKS”) applies to direct-to-consumer (“DTC”) prescription drug sales by manufacturers to cash-paying patients enrolled in federal health care programs. The Bulletin provides... READ MORE

Tags: , ,

Winning the COVID-19 Vaccine Lottery: OIG Weighs in on Anti-Kickback Implications of COVID-19 Vaccine Incentive Programs

[07/07/21]

Posted on July 7, 2021 in Health Law News

Published by: Hall Render

As the pandemic continues, health care providers, suppliers and managed care organizations are turning to incentive programs in an effort to boost COVID-19 vaccination rates. These programs offer various rewards, such as food and beverages or the chance to win free trips, cruises, groceries, event tickets or large cash prizes, to individuals who receive... READ MORE

Tags: , ,